The significant impact of naringin and its aglycone derivative naringenin on cardiovascular diseases

Globally, one major cause of morbidity and mortality is cardiovascular diseases (CVDs). The burden of cardiovascular disease among the elderly is still high and typically tends to move to nations with lower sociodemographic indices. Furthermore, despite being largely preventable, CVDs have a significant worldwide burden among children and young adults. Naringin and its aglycone naringenin are among the most well-known and significant flavonoids important for inhibiting or handling several illnesses, including diabetes, heart disease, obesity, metabolic syndrome, inflammatory, and neurodegenerative diseases. We investigated the pharmacological actions of naringin and naringenin in the treatment of CVDs and associated risks by reviewing in vitro, in vivo, and clinical studies obtained from the beginning until November 2024 on significant electronic databases. Through a variety of biochemical pathways, naringin and naringenin exhibited notable cardioprotective, anti-inflammatory, anti-atherogenic, and vascular benefits. They lowered hypertension, enhanced lipid profiles, and controlled critical signaling pathways linked to myocardial ischemia/reperfusion injury (MI/RI), cardiac hypertrophy (CH), and inflammation. These substances support cardiovascular health and may be used as treatment agents for associated disorders by altering important proteins, improving mitochondrial function, and increasing anti-oxidant and anti-inflammatory activities. • Cardiovascular diseases continue to act as a major contributor to disability and mortality worldwide. • Naringin and naringenin exhibited notable cardioprotective, anti-inflammatory, anti-atherogenic, and vascular benefits. • Naringin and naringenin lowered hypertension, enhanced lipid profiles, and controlled critical signaling pathways linked to myocardial ischemia/reperfusion injury, cardiac hypertrophy, and inflammation. • Naringin and naringenin support cardiovascular health and may be used as treatment agents for associated disorders.

Publication Details

Journal
Journal of Functional Foods
Published
2026-03-24
DOI
https://doi.org/10.1016/j.jff.2026.107249
Primary Topic
Cardiac Fibrosis and Remodeling
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The significant impact of naringin and its aglycone derivative naringenin on cardiovascular diseases

Journal of Functional Foods
Cardiac Fibrosis and Remodeling
article

The significant impact of naringin and its aglycone derivative naringenin on cardiovascular diseases

article en

Abstract

Globally, one major cause of morbidity and mortality is cardiovascular diseases (CVDs). The burden of cardiovascular disease among the elderly is still high and typically tends to move to nations with lower sociodemographic indices. Furthermore, despite being largely preventable, CVDs have a significant worldwide burden among children and young adults. Naringin and its aglycone naringenin are among the most well-known and significant flavonoids important for inhibiting or handling several illnesses, including diabetes, heart disease, obesity, metabolic syndrome, inflammatory, and neurodegenerative diseases. We investigated the pharmacological actions of naringin and naringenin in the treatment of CVDs and associated risks by reviewing in vitro, in vivo, and clinical studies obtained from the beginning until November 2024 on significant electronic databases. Through a variety of biochemical pathways, naringin and naringenin exhibited notable cardioprotective, anti-inflammatory, anti-atherogenic, and vascular benefits. They lowered hypertension, enhanced lipid profiles, and controlled critical signaling pathways linked to myocardial ischemia/reperfusion injury (MI/RI), cardiac hypertrophy (CH), and inflammation. These substances support cardiovascular health and may be used as treatment agents for associated disorders by altering important proteins, improving mitochondrial function, and increasing anti-oxidant and anti-inflammatory activities. • Cardiovascular diseases continue to act as a major contributor to disability and mortality worldwide. • Naringin and naringenin exhibited notable cardioprotective, anti-inflammatory, anti-atherogenic, and vascular benefits. • Naringin and naringenin lowered hypertension, enhanced lipid profiles, and controlled critical signaling pathways linked to myocardial ischemia/reperfusion injury, cardiac hypertrophy, and inflammation. • Naringin and naringenin support cardiovascular health and may be used as treatment agents for associated disorders.

Journal of Functional FoodsVol. 140
Good health and well-being
Openalex Percentile: Top 20%
Cardiac Fibrosis and Remodeling
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.